G. Verbruggen
- Rheumatology top 5%
- Pharmacology top 10%
- Cell Biology
- Molecular Biology
- Surgery
- Co-authors
- E M VeysStefan GoemaereDirk ElewautPeter VerdonkHerman MielantsStijn LambrechtK. SchelstraeteDieter Deforce
- Topics
- Osteoarthritis Treatment and Mechanisms (14 papers)Proteoglycans and glycosaminoglycans research (6 papers)Inflammatory mediators and NSAID effects (4 papers)
- Cited by
- RheumatologyEquinePharmacology
In The Last Decade
G. Verbruggen
26 papers receiving 481 citations
Peers
Comparison fields: 5 of 82
- Rheumatology 343
- Pharmacology 125
- Cell Biology 102
- Molecular Biology 96
- Surgery 90
Countries citing papers authored by G. Verbruggen
This map shows the geographic impact of G. Verbruggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Verbruggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Verbruggen more than expected).
Fields of papers citing papers by G. Verbruggen
This network shows the impact of papers produced by G. Verbruggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Verbruggen. The network helps show where G. Verbruggen may publish in the future.
Co-authorship network of co-authors of G. Verbruggen
This figure shows the co-authorship network connecting the top 25 collaborators of G. Verbruggen. A scholar is included among the top collaborators of G. Verbruggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Verbruggen. G. Verbruggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics. | 4 |
| 3 | 1 | |
| 4 | 65 | |
| 5 | 117 | |
| 6 | 55 | |
| 7 | 41 | |
| 8 | 14 | |
| 9 | 79 | |
| 10 | 1 | |
| 11 | Influence of interferon-gamma on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. | 11 |
| 12 | Influence of human recombinant interleukin-1 beta on human articular cartilage. Mitotic activity and proteoglycan metabolism. | 5 |
| 13 | 3 | |
| 14 | 1 | |
| 15 | [Physiopathology of arthrosis]. | 2 |
| 16 | 8 | |
| 17 | In vitro repair potential of articular cartilage: proteoglycan metabolism in the different areas of the femoral condyles in human cartilage explants. | 6 |
| 18 | Repair function in organ cultured human cartilage. Replacement of enzymatically removed proteoglycans during longterm organ culture. | 13 |
| 19 | 3 | |
| 20 | Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration. | 34 |
About G. Verbruggen
G. Verbruggen is a scholar working on Rheumatology, Immunology and Allergy and Cell Biology, having authored 26 papers that have together received 521 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (14 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Rheumatology (343 citations), Equine (17 citations) and Pharmacology (125 citations). G. Verbruggen has collaborated with scholars based in Belgium and France. Frequent co-authors include E M Veys, Stefan Goemaere, Dirk Elewaut, Peter Verdonk, Herman Mielants, Stijn Lambrecht, K. Schelstraete, Dieter Deforce, Karl Almqvist and Frank P. Luyten. Their work appears in journals such as Gastroenterology, Analytical Biochemistry and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.